The 2-Minute Rule for QST4
The key conclude level was the safety and tolerability of sifalimumab. Remedy-emergent adverse occasions (AEs) and serious AEs (SAEs) and their severity, outcome, and any marriage on the research medication were being recorded by the investigator all over the research. AEs were being regarded more likely to be linked to analyze medication when they